Table 1.
Participants’ characteristics
| Variables |
N = 87 Mean ± SD or N(%) |
|---|---|
| Age | 58 ± 13 |
| Male | 65(71) |
| Body mass index (Kg/m2) | 29 ± 5 |
| Heart rate (bpm) | 69 ± 11 |
| Systolic blood pressure (mmHg) | 129 ± 20 |
| Diastolic blood pressure (mmHg) | 74 ± 12 |
| Left bundle branch block on ECG | 6(7) |
| Clinical history | |
| Hypertension | 44(48) |
| Hyperlipidemia | 52(57) |
| Diabetes mellitus | 17(18) |
| Ever smoked | 33(36) |
| Heart failure | 17(18) |
| Myocardial infarction | 9(10) |
| Coronary stent | 27(32) |
| Coronary bypass graft | 13(14) |
| CMR assessment | |
| Left ventricular diastolic volume (ml/m2) | 86 ± 29 |
| Left ventricular systolic volume (ml/m2) | 46 ± 27 |
| Left ventricular ejection fraction (%) | 50 ± 12 |
| Left ventricular mass (g/m2) | 62 ± 16 |
| Regional wall motion abnormality in the analyzed images | 48 (52) |
| Left atrial volume (ml/m2) | 39 ± 16 |
| Late gadolinium enhancement | 45 (49) |
| Infarct pattern | 17 (19) |
| Non-infarct pattern | 27 (29) |
| CMR diagnosis | |
| Left ventricular hypertrophy | 13(14) |
| Myocardial infarction | 17(18) |
| Sarcoidosis | 9(10) |
| Myocarditis | 5(5) |
| Dilated cardiomyopathy | 6(7) |
| Hypertrophic cardiomyopathy | 2(3) |
| Amyloidosis | 1(1) |
| Churg-strauss endomyocarditis | 1(1) |